Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases

Anti-PD-1 antibodies (Abs) are among the optimal adjuvant therapies for melanoma at high risk of recurrence, especially BRAF wild-type melanoma, but the anti-tumour effects of anti-PD-1 Abs in the adjuvant setting for acral melanoma have not been evaluated previously. The aim of this study was to an...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito, Takeo Maekawa, Yasuhiro Fujisawa, Koji Yoshino, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, Ryo Amagai, Kentaro Ohuchi, Akira Hashimoto, Taku Fujimura
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Medical Journals Sweden 2022-08-01
Schriftenreihe:	Acta Dermato-Venereologica
Schlagworte:	adjuvant therapy acral melanoma anti-PD1 Abs RFS
Online-Zugang:	https://medicaljournalssweden.se/actadv/article/view/678
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!